Evidence map›Paper›PMID 36980543›Full record

ArticleCancers2023

Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver Disease.

Angelo Armandi, Gian Paolo Caviglia, Amina Abdulle, Chiara Rosso, Kamela Gjini, Gabriele Castelnuovo, Marta Guariglia, Nuria Perez Diaz Del Campo, Daphne D'Amato, Davide Giuseppe Ribaldone and 2 more

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Angelo ArmandiDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-7245-4445
Gian Paolo CavigliaDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-0529-9481
Amina AbdulleDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.
Chiara RossoDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0001-6518-7089
Kamela GjiniDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.
Gabriele CastelnuovoDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-9985-1440
Marta GuarigliaDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.
Nuria Perez Diaz Del CampoDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.
Daphne D'AmatoDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0001-9028-4040
Davide Giuseppe RibaldoneDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-9421-3087
Giorgio Maria SaraccoDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0001-5310-4143
Elisabetta BugianesiDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-0502-4381
University of Turin · ITJohannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) represents a relevant disease burden in cirrhotic patients with non-alcoholic fatty liver disease (NAFLD). We aimed to investigate the prognostic value of simple non-invasive tests (NITs) (AAR, APRI, BARD, FIB-4) for the stratification of HCC risk development in a cohort of 122 consecutive cirrhotic individuals with NAFLD. Over a median follow up of 5.9 (3.2-9.3) years, 13 (10.7%) developed HCC. Only FIB-4 was associated with HCC risk (HR = 1.27, 95% CI 1.03-1.58,

Indexed as

BARD scoreFIB-4 scorehepatocellular carcinomaliver cirrhosismetabolic syndromenon-alcoholic fatty liver diseasenon-invasive teststype 2 diabetes

Identifiers

PMID36980543
PMCPMC10046647
OpenAlexW4323566009

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read22
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.